BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 50 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,709,000 | -10.5% | 10,000,000 | -9.1% | 0.63% | +21.3% |
| Q2 2023 | $10,848,475 | -9.7% | 11,000,000 | -6.0% | 0.52% | +40.7% |
| Q1 2023 | $12,018,591 | +25.6% | 11,700,000 | +30.0% | 0.37% | +23.7% |
| Q4 2022 | $9,569,790 | +17.2% | 9,000,000 | +9.8% | 0.30% | +9.5% |
| Q3 2022 | $8,163,000 | +0.2% | 8,200,000 | 0.0% | 0.27% | +7.5% |
| Q2 2022 | $8,143,000 | +7.8% | 8,200,000 | +9.3% | 0.26% | +21.4% |
| Q1 2022 | $7,552,000 | – | 7,500,000 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 19,413,000 | $19,245,611 | 1.50% |
| SSI INVESTMENT MANAGEMENT LLC | 9,386,000 | $9,219,566 | 0.65% |
| PFM Health Sciences, LP | 15,000,000 | $14,771,520 | 0.57% |
| RWC Asset Management LLP | 11,000,000 | $10,848,475 | 0.52% |
| Sonora Investment Management Group, LLC | 6,280,000 | $6,184,858 | 0.52% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 24,020,000 | $23,654,128 | 0.46% |
| Lombard Odier Asset Management (Europe) Ltd | 7,224,000 | $7,124,489 | 0.34% |
| MACKAY SHIELDS LLC | 10,123,000 | $9,943,520 | 0.28% |
| PALISADE CAPITAL MANAGEMENT, LP | 9,478,000 | $9,323,983 | 0.25% |
| Nicholas Investment Partners, LP | 2,940,000 | $2,887,868 | 0.20% |